Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

On Nov. 23, five days before her scheduled flight home, she complained of exhaustion. One of her sons found her later passed ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

The FDA has accepted for review the BLA for mepolizumab as an add-on maintenance treatment for eosinophilic COPD.

CNW/ - Chronic diseases don't discriminate when it comes to age. A new report from Sun Life points to more and more young ...

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, ...

Obesity has this year overtaken smoking as Australia's leading risk factor contributing to disease, according to a national ...

Residents of Timișoara, in western Romania, can undergo free spirometry tests in a special tram as part of the ...